11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
Aethlon Medical Files Amendment to Prospectus Supplement for Common Stock
Other Events
Stockholders Approve Amendment to 2020 Equity Incentive Plan
Earnings Release
Aethlon Medical Enters Amendment to Securities Purchase Agreement
Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
FY 2025
Q3
Q2
Q1
FY 2024 amended
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload
Withdrawal of Offering Statement